Stearoyl-CoA Desaturase-1 and the Metabolic Syndrome

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 271-280

Bentham Science Publishers

Access to resources Recommend Favorite

Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase

By Dobrzyn Pawel   Dobrzyn Agnieszka  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. : 849-853

Informa Healthcare

Access to resources Recommend Favorite

Stearoyl-CoA Desaturase: A Vital Checkpoint in the Development and Progression of Obesity

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 3, 2011-09 ,pp. : 217-231

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Stearoyl-CoA Desaturase 1 Inhibitors for Dyslipidemia and Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 4, 2010-03 ,pp. : 419-433

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on Stearoyl-Coa Desaturase Regulation in Fatty Liver Diseases

By  

Current Drug Metabolism, Vol. 13, Iss. 10, 2012-12 ,pp. : 1454-1463

Bentham Science Publishers

Access to resources Recommend Favorite